Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Revenue
Total revenue	$ 774,208	$ 1,004,232
Operating Expenses and Costs
Practice salaries and benefits	402,366	583,156
Other practice operating expenses	313,976	482,583
Cost of product revenue	17,816	30,579
Selling, general and administrative expenses	629,415	999,443
Depreciation and amortization	28,024	86,509
Total Operating Expenses and Costs	1,391,597	2,182,270
Loss from operations	(617,389)	(1,178,038)
Other Income (Expenses)
Gain (loss) on extinguishment of debt	42,726	(96,660)
Loss on change in fair value of debt	(49,186)
Gain on change in fair value of derivative financial instruments	45,038
Amortization of original issue discounts on notes payable	(405,113)	(108,265)
Interest expense and other	(67,015)	(4,755)
Total other income (expenses)	(433,550)	(209,680)
Loss before provision for income taxes	(1,050,939)	(1,387,718)
Provision for income taxes
Net loss	$ (1,050,939)	$ (1,387,718)
Net loss per share, basic and diluted:
Basic (in Dollars per share)	$ 0	$ 0
Fully diluted (in Dollars per share)	$ 0	$ 0
Weighted average number of common shares:
Basic (in Shares)	281,947,151	280,484,268
Fully diluted (in Shares)	281,947,151	280,484,268
Patient service revenue, net
Revenue
Total revenue	$ 752,015	$ 963,621
Subscription revenue
Revenue
Total revenue	9,584	7,628
Product revenue
Revenue
Total revenue	$ 12,609	$ 32,983